Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

4.47
-0.1000-2.19%
Post-market: 4.470.00000.00%16:10 EDT
Volume:96.10K
Turnover:430.37K
Market Cap:261.59M
PE:-4.03
High:4.62
Open:4.62
Low:4.43
Close:4.57
52wk High:5.42
52wk Low:2.20
Shares:58.52M
Float Shares:29.59M
Volume Ratio:0.79
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1091
EPS(LYR):-1.1091
ROE:-109.41%
ROA:-33.90%
PB:4.88
PE(LYR):-4.03

Loading ...

Orchestra BioMed presentation highlights pivotal trials for hypertension pacing, sirolimus artery therapy

Reuters
·
Apr 06

Orchestra BioMed publishes corporate deck highlighting pivotal AVIM hypertension, Virtue SAB artery disease trials

Reuters
·
Mar 30

Orchestra BioMed Publishes CRT 2026 AVIM Therapy Presentation

Reuters
·
Mar 24

Analysts’ Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)

TIPRANKS
·
Mar 18

Orchestra BioMed CEO and Chairperson David P. Hochman acquires USD 42,900 in common shares

Reuters
·
Mar 17

Orchestra BioMed Hldgs Q4 EPS $0.26 Beats $(0.39) Estimate, Sales $30.917M Beat $878.600K Estimate

Benzinga
·
Mar 12

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

GlobeNewswire
·
Mar 12

Orchestra BioMed FY2025 net loss narrows 14% to USD 52.7 million

Reuters
·
Mar 12

Orchestra BioMed: Undervalued Cardiovascular Innovator Poised for Multi‑Year Catalyst Cycle

TIPRANKS
·
Mar 12

Orchestra BioMed management to meet with B. Riley

TIPRANKS
·
Mar 09

BRIEF-Orchestra Biomed Announces Presentations Highlighting Avim Therapy Potential Impact On Hypertensive Heart Disease And Heart Failure At Tht And Crt

Reuters
·
Mar 03

Orchestra BioMed to Present AVIM Therapy Data at THT and CRT 2026 Meetings

Reuters
·
Mar 03

Orchestra Biomed Announces Presentations Highlighting Avim Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at Tht and Crt

THOMSON REUTERS
·
Mar 03

Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC)

TIPRANKS
·
Feb 21

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

GlobeNewswire
·
Feb 19

Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan

TIPRANKS
·
Feb 14

Orchestra BioMed Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Feb 14

Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 14

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 14

Orchestra Biomed Unveils Vision for Growth With Updates on Pivotal Cardiovascular Trials and Strategic Partnerships

Reuters
·
Feb 06